Omeros (OMER) Interest Expenses (2010 - 2026)
Omeros recorded quarterly Interest Expenses of $5.9 million in Q1 2026, down 32.45% quarter-over-quarter from $8.7 million in Q4 2025, and up 61.3% year-over-year from $3.7 million in Q1 2025.
Omeros' Interest Expenses history runs 17 years deep, the most recent figure standing at $5.9 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 61.3% year-over-year to $5.9 million; the TTM figure through Mar 2026 stood at $1.3 million (down 93.63% YoY), while the FY2025 annual figure was -$960000.0, down 292.0% from the prior year.
- Interest Expenses came in at $5.9 million for Q1 2026 at Omeros, down from $8.7 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $9.2 million in Q2 2024 to a low of -$13.4 million in Q3 2025.
- A 5-year average of $4.9 million and a median of $5.9 million in 2026 frame the typical range for Interest Expenses.
- On a YoY basis, Interest Expenses climbed as much as 174.66% in 2025 and fell as far as 429.59% in 2025.
- Omeros' Interest Expenses stood at $7.9 million in 2022, then slipped by 10.63% to $7.1 million in 2023, then sank by 55.02% to $3.2 million in 2024, then soared by 174.66% to $8.7 million in 2025, then slumped by 32.45% to $5.9 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $5.9 million, $8.7 million, and -$13.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 5.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.89 Mn |
| Mar 31, 2026 | 5.89 Mn |
| Dec 31, 2025 | 8.73 Mn |
| Dec 31, 2025 | 8.73 Mn |
| Sep 30, 2025 | -13.36 Mn |
| Sep 30, 2025 | -13.36 Mn |
| Jun 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 3.65 Mn |
| Mar 31, 2025 | 3.65 Mn |
| Dec 31, 2024 | 3.18 Mn |
| Dec 31, 2024 | 3.18 Mn |
| Sep 30, 2024 | 4.05 Mn |
| Sep 30, 2024 | 4.05 Mn |
| Jun 30, 2024 | 9.22 Mn |
| Jun 30, 2024 | 9.22 Mn |
| Mar 31, 2024 | 8.23 Mn |
| Mar 31, 2024 | 8.23 Mn |
| Dec 31, 2023 | 7.06 Mn |
| Dec 31, 2023 | 7.06 Mn |
| Sep 30, 2023 | 7.92 Mn |
| Sep 30, 2023 | 7.92 Mn |
| Jun 30, 2023 | 7.93 Mn |
| Jun 30, 2023 | 7.93 Mn |
| Mar 31, 2023 | 7.93 Mn |
| Mar 31, 2023 | 7.93 Mn |
| Dec 31, 2022 | 7.90 Mn |
| Dec 31, 2022 | 7.90 Mn |
| Sep 30, 2022 | 4.93 Mn |
| Sep 30, 2022 | 4.93 Mn |
| Jun 30, 2022 | 4.93 Mn |
| Jun 30, 2022 | 4.93 Mn |
| Mar 31, 2022 | 4.94 Mn |
| Mar 31, 2022 | 4.94 Mn |
| Dec 31, 2021 | 4.95 Mn |
| Dec 31, 2021 | 4.95 Mn |
| Sep 30, 2021 | 4.91 Mn |
| Sep 30, 2021 | 4.91 Mn |
| Jun 30, 2021 | 4.91 Mn |
| Jun 30, 2021 | 4.91 Mn |
| Mar 31, 2021 | 4.90 Mn |
| Mar 31, 2021 | 4.90 Mn |
| Dec 31, 2020 | 7.99 Mn |
| Dec 31, 2020 | 7.99 Mn |
| Sep 30, 2020 | 6.88 Mn |
| Sep 30, 2020 | 6.88 Mn |
| Jun 30, 2020 | 5.98 Mn |
| Jun 30, 2020 | 5.98 Mn |
| Mar 31, 2020 | 5.90 Mn |
| Mar 31, 2020 | 5.90 Mn |
| Dec 31, 2019 | 5.81 Mn |
| Dec 31, 2019 | 5.81 Mn |
| Sep 30, 2019 | 5.72 Mn |
| Sep 30, 2019 | 5.72 Mn |
| Jun 30, 2019 | 5.53 Mn |
| Jun 30, 2019 | 5.53 Mn |
| Mar 31, 2019 | 5.60 Mn |
| Mar 31, 2019 | 5.60 Mn |
| Dec 31, 2018 | 5.15 Mn |
| Dec 31, 2018 | 5.15 Mn |
| Sep 30, 2018 | 4.60 Mn |
| Sep 30, 2018 | 4.60 Mn |
| Jun 30, 2018 | 3.68 Mn |
| Jun 30, 2018 | 3.68 Mn |
| Mar 31, 2018 | 2.83 Mn |
| Mar 31, 2018 | 2.83 Mn |
| Dec 31, 2017 | 2.86 Mn |
| Dec 31, 2017 | 2.86 Mn |
| Sep 30, 2017 | 2.78 Mn |
| Sep 30, 2017 | 2.78 Mn |
| Jun 30, 2017 | 2.72 Mn |
| Jun 30, 2017 | 2.72 Mn |
| Mar 31, 2017 | 2.66 Mn |
| Mar 31, 2017 | 2.66 Mn |
| Dec 31, 2016 | 2.45 Mn |
| Dec 31, 2016 | 2.45 Mn |
| Sep 30, 2016 | 2.14 Mn |
| Sep 30, 2016 | 2.14 Mn |
| Jun 30, 2016 | 1.86 Mn |
| Jun 30, 2016 | 1.86 Mn |
| Mar 31, 2016 | 1.38 Mn |
| Mar 31, 2016 | 1.38 Mn |
| Dec 31, 2015 | 808,000.00 |
| Dec 31, 2015 | 808,000.00 |
| Sep 30, 2015 | 871,000.00 |
| Sep 30, 2015 | 871,000.00 |
| Jun 30, 2015 | 937,000.00 |
| Jun 30, 2015 | 937,000.00 |
| Mar 31, 2015 | 957,000.00 |
| Mar 31, 2015 | 957,000.00 |
| Dec 31, 2014 | 915,000.00 |
| Dec 31, 2014 | 915,000.00 |
| Sep 30, 2014 | 944,000.00 |
| Sep 30, 2014 | 944,000.00 |
| Jun 30, 2014 | 939,000.00 |
| Jun 30, 2014 | 939,000.00 |
| Mar 31, 2014 | 672,000.00 |
| Mar 31, 2014 | 672,000.00 |
| Dec 31, 2013 | 598,000.00 |
| Dec 31, 2013 | 598,000.00 |
| Sep 30, 2013 | 592,000.00 |
| Sep 30, 2013 | 592,000.00 |
| Jun 30, 2013 | 589,000.00 |
| Jun 30, 2013 | 589,000.00 |
| Mar 31, 2013 | 587,000.00 |
| Mar 31, 2013 | 587,000.00 |
| Dec 31, 2012 | 369,000.00 |
| Dec 31, 2012 | 369,000.00 |
| Sep 30, 2012 | 413,000.00 |
| Sep 30, 2012 | 413,000.00 |
| Jun 30, 2012 | 453,000.00 |
| Jun 30, 2012 | 453,000.00 |
| Mar 31, 2012 | 494,000.00 |
| Mar 31, 2012 | 494,000.00 |
| Dec 31, 2011 | 536,000.00 |
| Dec 31, 2011 | 536,000.00 |
| Sep 30, 2011 | 528,000.00 |
| Sep 30, 2011 | 528,000.00 |
| Jun 30, 2011 | 527,000.00 |
| Jun 30, 2011 | 527,000.00 |
| Mar 31, 2011 | 293,000.00 |
| Mar 31, 2011 | 293,000.00 |
| Dec 31, 2010 | 312,000.00 |
| Dec 31, 2010 | 312,000.00 |
| Sep 30, 2010 | 362,000.00 |
| Sep 30, 2010 | 362,000.00 |
| Jun 30, 2010 | 409,000.00 |
| Jun 30, 2010 | 409,000.00 |